Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Genomics, |
RCV000576627 | SCV000678239 | uncertain significance | Weill-Marchesani 4 syndrome, recessive | 2021-12-22 | criteria provided, single submitter | clinical testing | ADAMTS17 NM_139057 exon 13 p.Leu623Pro (c.1868T>C): This variant has not been previously reported in the literature but has been identified in 46/33582 Latino chromosomes in the Genome Aggregation Database (http://gnomad.broadinstitute.org/rs200371613). Evolutionary conservation and computational predictive tools for this variant are unclear. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Labcorp Genetics |
RCV001853827 | SCV002207202 | uncertain significance | not provided | 2022-08-07 | criteria provided, single submitter | clinical testing | This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 623 of the ADAMTS17 protein (p.Leu623Pro). This variant is present in population databases (rs200371613, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with ADAMTS17-related conditions. ClinVar contains an entry for this variant (Variation ID: 487472). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Not Available"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |